Federal Magistrate Margaret Garnett has closed the door to the death penalty in the case of Luigi Mangione, a 27-year-old man accused of shooting and killing Brian Thompson, CEO of UnitedHealthcare, on December 4, 2024 in Manhattan. The decision, adopted this Friday, responds to a defense motion and a strict interpretation of what crimes can be considered a “violent crime” under federal law to open the possibility of execution.
Why the death penalty is no longer contemplated
Judge Garnett agreed to withdraw the third and fourth charges in the case: interstate harassment and murder with a firearm, which were what turned the process into a case with the possibility of capital punishment. According to the judge, these charges do not meet the federal legal definition of “violent crime” as a matter of law, a key criterion for the prosecution to request the death penalty.
“This case will move forward with trial on counts one and two, which charge the defendant with causing the death of Brian Thompson under federal anti-harassment laws,” Garnett explained in his ruling. Each of these crimes has the maximum penalty of life imprisonment without the possibility of parole, which keeps an extremely severe sentence in the air, although not execution.
The defense strategy and the controversy over the registry
Mangione’s defense had filed a motion to dismiss the death penalty charges, arguing that his client does not fit into the category of “violent offender” under the strict interpretation of federal law. Additionally, the legal team attempted to have the evidence found in Mangione’s backpack at the time of his arrest excluded from the trial, alleging that the search was illegal because there was no court order.
However, the judge also ruled this Friday that this evidence will be admitted at trial. Among the items recovered were a pistol and a full magazine, items that prosecutors could use to link Mangione to Thompson’s murder. The admission of this evidence reinforces the line of the accusation, which maintains that the young man acted premeditatedly and with lethal weapons.
The context of the murder and the media impact
On December 4, 2024, Brian Thompson was shot in the chest in front of a hotel in downtown Manhattan, in an attack that shocked public opinion and put the spotlight on tensions between large health insurance companies and groups critical of his management. Mangione, 27, was arrested shortly after in Pennsylvania and has pleaded not guilty to all charges.
The case has acquired an almost symbolic character: Thompson was one of the top managers of UnitedHealthcare, one of the largest health insurers in the United States, and the crime occurred in a context of growing distrust towards the private health system.
Although Mangione no longer faces the death penalty, the trial promises to be one of the most followed in recent years due to its mix of violence, social criticism and debate on the use of capital punishment in crimes of this type.
What can happen in the trial and the debate on the death penalty
With the death penalty ruled out, the focus of the process shifts to the classification of the remaining crimes and the possible accumulation of sentences that could lead to life in prison without parole. The prosecution will have to prove, in addition to authorship of the shooting, that Mangione acted with intention and within the framework of a pattern of harassment that fits into current federal laws.
Judge Garnett’s decision has reopened the debate on the application of the death penalty in the United States, especially in cases that, like this one, combine violent crime, political or social motivations, and a strong media echo. For many experts, the ruling underscores the importance of charges conforming to very specific legal definitions, while for others it reflects the difficulty of maintaining capital punishment in contexts where the interpretation of the law becomes restrictive.
